DN — Delta 9 Cannabis Cashflow Statement
0.000.00%
- CA$3.52m
- CA$67.00m
- CA$71.07m
- 50
- 92
- 21
- 54
Annual cashflow statement for Delta 9 Cannabis, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.7 | -5.49 | -11.1 | -27.8 | -16.6 |
| Depreciation | |||||
| Non-Cash Items | -15.9 | 3.36 | 4.95 | 8.59 | 6.33 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.4 | -1.69 | -1.06 | 7.62 | 5.74 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.1 | 1.51 | -0.775 | -3.66 | 4.22 |
| Capital Expenditures | -14 | -5.84 | -2.58 | -2.36 | -0.652 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.033 | -0.48 | -0.281 | -11.5 | 0.02 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -14.1 | -6.32 | -2.86 | -13.9 | -0.632 |
| Financing Cash Flow Items | 3.9 | 5.31 | 0.597 | -0.012 | -1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.8 | 7.04 | -1.54 | 16.8 | -4.96 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10.4 | 2.23 | -5.18 | -0.722 | -1.37 |